Insider filing · REGN
George L Sing
Director
profile →
Regeneron Pharmaceuticals, Inc.
REGN · Healthcare · 35 filings in 24 months
ticker →
George L Sing sold $20.4M of Regeneron Pharmaceuticals (REGN)
Executed Nov 2, disclosed Nov 4, 2 days later.
Value, as filed
$20.4M
21,129 sh across 9 lots
Executed
Nov 2
the trade date, as filed
Disclosed
Nov 4
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
GSGeorge L Sing (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Regeneron Pharmaceuticals, Inc. (REGN). The largest single filing was $20.4M of REGN (21,129 sh across 9 lots, as filed), executed Nov 2.
The name
REGNHealthcare · Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→